Systemic lupus international collaborating clinics renal activity/response exercise: Development of a renal activity score and renal response index

Arthritis and Rheumatism

Volumn 58, Issue 6, 2008, Pages 1784-1788

  Petri, Michelle ^a   Kasitanon, Nuntana ^a   Lee, Shin Seok ^a   Link, Kimberly ^a   Magder, Laurence ^b   Bae, Sang Cheol ^c   Hanly, John G ^d   Isenberg, David A ^e   Nived, Ola ^f   Sturfelt, Gunnar ^f   Van Vollenhoven, Ronald ^g   Wallace, Daniel J ^h   Alarcón, Graciela S ⁱ   Adu, Dwomoa ^j   Avila Casado, Carmen ^k   Bernatsky, Sasha R ^l   Bruce, Ian N ^m   Clarke, Ann E ^l   Contreras, Gabriel ⁿ   Fine, Derek M ^a   Gladman, Dafna D ^o   Gordon, Caroline ^p   Kalunian, Kenneth C ^q   Madaio, Michael P ^r   Rovin, Brad H ^s   Sanchez Guerrero, Jorge ^t   Steinsson, Kristjan ^u   Aranow, Cynthia ^v   Balow, James E ^w   Buyon, Jill P ^x   Ginzler, Ellen M ^y   Khamashta, Munther A ^z   Urowitz, Murray B ^o   Dooley, Mary Anne ^aa   Merrill, Joan T ^ab   Ramsey Goldman, Rosalind ^ac   Font, Josef ^ag   Tumlin, James ^ad   Stoll, Thomas ^ae   Zoma, Asad ^af   more..

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c Hanyang University Medical Center   (South Korea)

^d QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^j QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^k INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^l MONTREAL GENERAL HOSPITAL   (Canada)

^m MANCHESTER ROYAL INFIRMARY   (United Kingdom)

ⁿ UNIVERSITY OF MIAMI   (United States)

^o UNIVERSITY OF TORONTO   (Canada)

^p UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^t Instituto National de la Nutricion   (Mexico)

^u LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^v NewYork Presbyterian Hospital   (United States)

^w NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^x NYU HOSPITAL FOR JOINT DISEASES   (United States)

^y SUNY DOWNSTATE MEDICAL CENTER   (United States)

^z ST THOMAS HOSPITAL   (United Kingdom)

^aa UNIVERSITY OF NORTH CAROLINA   (United States)

^ab OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^ac NORTHWESTERN UNIVERSITY   (United States)

^ad UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^ae KANTONSSPITAL   (Switzerland)

^af HAIRMYRES HOSPITAL   (United Kingdom)

^ag NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONFIDENCE INTERVAL; DISEASE ACTIVITY; DISEASE SEVERITY; ERYTHROCYTE COUNT; FEMALE; HUMAN; KIDNEY FUNCTION; KIDNEY RESPONSE INDEX; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEPHROLOGIST; PHYSICIAN; PRIORITY JOURNAL; PROTEINURIA; RATING SCALE; REGRESSION ANALYSIS; RHEUMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; URINALYSIS;

HUMANS; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; OBSERVER VARIATION; SEVERITY OF ILLNESS INDEX;

EID: 45349102050     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23456     Document Type: Article

References (18)

1. Petri M. Systemic lupus erythematosus. In: Lichtenstein LM, Busse WW, Geha RS, editors. Current therapy in allergy, immunology, and rheumatology. 6th ed. St. Louis: Mosby; 2004. p. 239-42.
2. Alarcon-Segovia D, Tumlin JA, Furie RA, McKay JD, Cardiel MH, Strand V, et al, and the LJP 394 Investigator Consortium. LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study. Arthritis Rheum 2003;48:442-54.
3. Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005;353:2219-28.
4. Petri M, Barr SG, Buyon J, Davis J, Ginzler E, Kalunian K, et al. RIFLE: Responder Index for Lupus Erythematosus [abstract]. Arthritis Rheum 2000;43 Suppl 9:S244.
5. Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. QJM 1993;86:447-58.
6. Petri M, Kasitanon N, Singh S, Link K, Magder L, Bae SC, et al, for the Systemic Lupus International Collaborating Clinics. Systemic Lupus International Collaborating Clinics Renal Activity/Response Exercise: comparison of agreement in renal response. Arthritis Rheum 2008;58:1789-95.
7. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
8. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict GFR from S-creatinine [abstract]. J Am Soc Nephrol 2000;11:155A.
9. Churg J, Sobin LH. Classification of glomerular disease. In: Churg J, Sobin LH, editors. Renal disease classification and atlas of glomerular diseases. Tokyo: Igaku-Shoin; 1982. p. 3-19.
10. Churg J, Bernstein J, Glassock RJ. Classification of glomerular disease. In: Churg J, Bernstein J, Glassock RJ, editors. Renal disease classification and atlas of glomerular diseases. 2nd ed. Tokyo: Igaku-Shoin; 1995. p. 151-6.
11. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15:241-50.
12. Classification and Response Criteria Subcommittee of the American College of Rheumatology Committee on Quality Measures. Development of classification and response criteria for rheumatic diseases. Arthritis Rheum 2006;55:348-52.
13. Burt RK, Traynor A, Statkute L, Barr WG, Rosa R, Schroeder J, et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 2006;295:527-35.
14. Kasitanon N, Fine DM, Haas M, Magder LS, Petri M. Hydroxychloroquine use predicts complete renal remission within 12-months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis. Lupus 2006;15:366-70.
15. Renal Disease Subcommittee of the American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria. The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 2006;54:421-32.
16. Wilmer WA, Rovin BH, Herbert Gf, Rao SV, Kumor K, Herbert LA. Management of glomerular proteinuria: a commentary. J Am Soc Nephrol 2003;14:3217-32.
17. Shidham G, Hebert LA. Timed urine collections are not needed to measure urine protein excretion in clinical practice. Am J Kidney Dis 2006;47:8-14.
18. Christopher-Stine L, Petri M, Astor BC, Fine D. Urine protein-to-creatinine ratio is a reliable measure of proteinuria in lupus nephritis. J Rheumatol 2004;31:1557-9.